4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Hyperinsulinism in 2 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have shown that hyperinsulinemia in HC rats involves a programmed hyperresponsiveness to glucose." | 1.34 | Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. ( Dodds, C; Mitrani, P; Patel, MS; Srinivasan, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrani, P | 1 |
| Srinivasan, M | 1 |
| Dodds, C | 1 |
| Patel, MS | 1 |
| Chapa, AM | 1 |
| Fernandez, JM | 1 |
| Thompson, DL | 1 |
| Tempelman, RJ | 1 |
| Berrio, LF | 1 |
| Croom, WJ | 1 |
| Hagler, WM | 1 |
2 other studies available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Hyperinsulinism
| Article | Year |
|---|---|
Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; A | 2007 |
Endocrine and metabolic response to muscarinic stimulation and inhibition in the ruminant: effects of slaframine.
Topics: Alkaloids; Animals; Blood Glucose; Endocrine Glands; Fatty Acids, Nonesterified; Female; Goat Diseas | 1995 |